Global Ophthalmic Diagnostic Devices Market

Ophthalmic Diagnostic Devices Market Size, Share, Growth Analysis, By Type(Optical Coherence Tomography, Aberrometer & Topography Systems, Fundus Camera, Ophthalmic Ultrasound), By End User(Hospitals, Ophthalmic Clinics, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2725 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 77

Ophthalmic Diagnostic Devices Market Insights

Ophthalmic Diagnostic Devices Market size was valued at USD 2.56 billion in 2022 and is poised to grow from USD 2.71 billion in 2023 to USD 4.40 billion by 2031, at a CAGR of 6.2% during the forecast period (2024-2031)

There has been an advance in knowledge of ocular illnesses and diseases. This is mostly attributable to the rise in the use of online tools and resources that inform the general public about various kinds of ocular problems and methods of diagnosis.

Active activities by ocular health-focused governmental and non-governmental organizations would additionally favorably affect market expansion over the course of the projection year. Currently, both big-name companies and small businesses provide a variety of ophthalmic devices for diagnostic use.

The market for ophthalmic diagnostic devices is anticipated to grow significantly over the next few years as a result of the increasing adoption of advanced diagnostic tools in developed nations like the U.S., Japan, Germany, and France.

Ocular diseases, particularly cataracts and glaucoma, are becoming more common on a global scale. Around 20 million people worldwide are estimated to have cataract-related blindness, according to estimates from the World Health Organization (WHO).

Key companies are projected to continuously innovate by creating cutting-edge diagnostic tools for the diagnosis of ocular disorders. The demand for ocular diagnostic devices is also anticipated to expand in emerging nations during the forecast period as a result of changing healthcare infrastructure and a rise in the availability of ophthalmology gadgets.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Ophthalmic Diagnostic Devices Market size was valued at USD 2.56 billion in 2022 and is poised to grow from USD 2.71 billion in 2023 to USD 4.40 billion by 2031, at a CAGR of 6.2% during the forecast period (2024-2031)

The competitive landscape of the ophthalmic diagnostic devices market is characterized by the presence of several key players who offer a wide range of technologically advanced products. These companies strive to develop innovative devices that provide accurate and efficient diagnosis, enabling better patient care. 'Carl Zeiss Meditec AG', 'Topcon Corporation', 'Nidek Co., Ltd.', 'Haag-Streit AG', 'Alcon, Inc.', 'Essilor International S.A.', 'Heidelberg Engineering GmbH', 'Novartis AG', 'Bausch + Lomb Incorporated', 'Johnson & Johnson Vision', 'CooperVision, Inc.', 'Canon Inc.', 'Allergan plc', 'Ziemer Group Holding AG', 'Optovue, Inc.', 'Lumenis Ltd.', 'Leica Microsystems GmbH', 'Hoya Corporation', 'Santen Pharmaceutical Co., Ltd.', 'Oculus Optikgeräte GmbH', 'STAAR Surgical Company', 'Reichert Technologies'

The global healthcare expenditure has been steadily increasing, driven by economic growth, expanding health insurance coverage, and government initiatives to improve healthcare infrastructure. This rise in healthcare spending has positively impacted the ophthalmic diagnostic devices market as healthcare facilities and professionals invest in advanced diagnostic equipment to deliver high-quality eye care services.

Ophthalmic diagnostic devices generate a vast amount of data, including imaging data, patient records, and treatment outcomes. The integration of big data analytics allows for efficient storage, analysis, and interpretation of this data, enabling better decision-making, personalized treatment plans, and the development of predictive models for disease progression.

It is expected that North America would hold the largest share of this market, with revenue of USD 907.2 million in 2022. The market for ophthalmic diagnostic devices in the area is anticipated to be driven by high adoption of cutting-edge ophthalmology diagnostic tools, growing awareness of ocular ailments, and rising prevalence of refractive error disorders. Approximately 35.1% of Americans under 50 are myopic, according to a Journal of Current Ophthalmology report. In the upcoming years, it is predicted that the market in this region will grow because of the increased frequency of cataract and myopia.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Ophthalmic Diagnostic Devices Market

Report ID: SQMIG35A2725

$5,300
BUY NOW GET FREE SAMPLE